The yeast Pdr5p multidrug transporter: How does it recognize so many substrates?

Biochemical and Biophysical Research Communications

Volumn 356, Issue 1, 2007, Pages 1-5

  Golin, John ^a   Ambudkar, Suresh V ^b   May, Leopold ^a  

^a CATHOLIC UNIVERSITY OF AMERICA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ABC transporter; Pdr5; Substrate specificity; Yeast multidrug resistance

Indexed keywords

ABC TRANSPORTER; CLOTRIMAZOLE; GLYCOPROTEIN P; IMIDAZOLE DERIVATIVE; ORGANOTIN COMPOUND; PROTEIN PDR5P; TRITYLIMIDAZOLE; UNCLASSIFIED DRUG;

BINDING SITE; CANCER; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TRANSPORT; HYDROPHOBICITY; INFECTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN FAMILY; SHORT SURVEY; YEAST;

ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; HYDROPHOBICITY; IMIDAZOLES; SACCHAROMYCES CEREVISIAE PROTEINS; SUBSTRATE SPECIFICITY;

EID: 33947133660     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.011     Document Type: Short Survey

References (34)

1. Taglicht D., and Michaelis S. Saccharomyces cerevisiae ABC proteins and their relevance to human disease. Methods Enzymol. 292 (1998) 130-162
2. Rogers B., Decottignies A., Kolaczkowski M., Caravajal E., Moye-Rowley W.S., and Goffeau A. The pleiotropic drug ABC transporters from Saccharomyces cerevisiae. J. Mol. Microbiol. Biotechnol. 3 (2001) 207-214
3. Jungwirth H., and Kuchler K. Yeast ABC transporters-A tale of sex, stress, drugs and aging. FEBS Lett. 580 (2006) 1131-1138
4. Kolaczkowski M., Kolaczkowski A., Luczynski J., Wilek S., and Goffeau A. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network. Microb. Drug Resist. 4 (1998) 143-158
5. Leppert G., McDevitt R., Falco S.V., Van Dyk T.K., and Golin J. Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces. Genetics 125 (1990) 13-20
6. Balzi E., Wang M., Leterme S., van Dyck L., and Goffeau A. PDR5, a novel yeast multidrug transporter controlled by the transcriptional regulator PDR1. J. Biol. Chem. 269 (1994) 2206-2214
7. Bissinger P.H., and Kuchler K. Molecular cloning of the Saccharomyces cerevisiae STS1 gene product. J. Biol. Chem. 269 (1994) 4180-4186
8. Leonard P., Rathod P., and Golin J. Loss-of-function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol efflux. Antimicrob. Agents Chemother. 38 (1994) 2492-2494
9. Meyers S., Schauer S., Balzi W., Wagner E., Goffeau M., and Golin J. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr. Genet. 21 (1992) 431-436
10. Katzmann D., Burnett P., Golin J., Mahe Y., and Moye-Rowley W.S. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol. Cell. Biol. 14 (1994) 4653-4661
11. Hellauer K., Akache B., MacPherson S., Sirard E., and Turcotte B. Zinc cluster protein Rdr1 is a transcriptional repressor of the PDR5 gene encoding a multidrug transporter. J. Biol. Chem. 278 (2002) 17671-17676
12. Gao C., Wang L., Milgrom E., and W-Shen W.C. On the mechanism of constitutive Pdr1 activator-mediated PDR5 transcription in Saccharomyces cerevisiae: evidence for enhanced recruitment of coactivators and altered nucleosome structure. J. Biol. Chem. 279 (2004) 42677-42686
13. Soud A.K., Gao C., Wang L., Milgrom E., and W-Shen W.C. ELM1 is required for multidrug resistance in Saccharomyces cerevisiae. Genetics 173 (2006) 1919-1937
14. Decottignies A., grant A.M., Nichols J.W., deWet H., McIntosh D.B., and Goffeau A. ATPase and multidrug transport activities of overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273 (1998) 12612-12803
15. Decottignies A., Kolaczkowski M., Balzi E., and Goffeau A. Solubilization and characterization of overexpressed Pdr5 multidrug resistance nucleotide triphosphatase of yeast. J. Biol. Chem. 269 (1994) 12797-12803
16. Kolaczkowski M., Vanderest M., Cybularz-Kolaczkowski A., Soumilluion J., Konigs W., and Goffeau A. Anticancer drugs, ionophoric peptides and steroids as substrates of the yeast multidrug transporter Pdr5p. J. Biol. Chem. 271 (1996) 31543-31548
17. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2 (2002) 48-58
18. Ambudkar S.V., Kimchi-Sarfaty C., Sauna Z.E., and Gottesman M.M. P-glycoprotein: from genomics to mechanism. Oncogene 22 (2003) 7468-7485
19. Golin J., Barkatt A., Cronin S., Eng G., and May L. Chemical specificity of the PDR5 multidrug resistance gene based on studies with tri-n-alkyltin chlorides. Antimicrob. Agents Chemother. 44 (2000) 134-139
20. Golin J., Ambudkar S.V., Gottessman M., Habib A.D., Sczepanski J., Ziccardi W., and May L. Studies with novel Pdr5p substrates demonstrate strong size dependence for xenobiotic efflux. J. Biol. Chem. 278 (2003) 5963-5969
21. Dey S., Ramachandra M., Pastan I., Gottesman M.M., and Ambudkar S.V. Evidence for nonidentical drug-interaction sites in human P-glycoprotein. PNAS (USA) 94 (1997) 10594-10599
22. Ambudkar S.V., Kim I.-W., and Sauna Z.E. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). Eur. J. Pharm. Sci. 27 (2006) 392-400
23. Hanson L., May L., Tuma P., Keeven J., Mehl P., Ferenz M., Ambudkar S.V., and Golin J. The role of hydrogen-bond acceptor groups in the interaction of substrates with Pdr5p, a major yeast drug transporter. Biochemistry 44 (2005) 9703-9713
24. Yu E., McDermott G., Zgurskaya H., Nikaido H., and Koshland D. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300 (2003) 976-980
25. Schumacher M., Miller M., and Brennan M.R. Structural mechanism of simultaneous binding of two drugs to a multidrug-binding protein. EMBO J. 23 (2004) 2923-2930
26. Maki N., Moitra K., Silver C., Ghosh P., Chattupadhyah A., and Dey S. Modulator-induced interference in functional cross talk between the substrate and ATP sites of human P-glycoprotein. Biochemistry 45 (2006) 2739-2751
27. J. Golin, Z.N. Kon, J. Martello, L. Hanson, S. Supernavage, S.V. Ambudkar, and Z. Sauna, Inhibition of the Pdr5p-multidrug efflux pump ATPase activity by its transport substrates suggests that GTP as well as ATP may be used as an energy source (in review).
28. Egner R., Bauer B.E., and Kuchler K. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5p ATP-binding cassette multidrug resistance transporter. Mol. Cell. Biol. 9 (1998) 523-545
29. Tutulan-Cunita A., Mikoshi M., Mizunuma M., Hirata D., and Miyakawa T. Mutational analysis of the yeast multidrug transporter Pdr5p with altered drug specificity. Genes to Cells 10 (2004) 409-420
30. Shukla S., Sani P., Smirti S., Jha S., Ambudkar S.V., and Prasad R. Functional characterization of the Candida albicans ABC transporter Cdr1p. Eukaryotic Cell 2 (2003) 1361-1375
31. Penzotti J.E., Lamb M., Evensen E., and Grootenhaus P. A computational ensemble pharmacophore model of identifying substrates of P-glycoprotein. J. Med. Chem. 45 (2002) 1737-1740
32. Gatlik-Landwojtowicz E., Aanismaa P., and Seelig A. Quantification and characterization of P-glycoprotein-substrate interaction. Biochemistry 45 (2006) 3020-3032
33. Reid R.J.D., Kauh E.A., and Bjonsti M. Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast. J. Biol. Chem. 272 (1997) 12091-12099
34. Servos J., Haase E., and Brendel M. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol. Genet. Genomics 236 (1993) 214-218